Biotech RadarJobs updated

COMPANY

Public Health Vaccines

phvaccines.com ↗

Clinical Phase 1

Profile checked Oct 10, 2026

Keywords: Nipah Virus Infection Marburg Virus Disease PHV02 PHV01

3Trials (company is sponsor)

Timeline

  1. Trial start Phase 1: Study to Evaluate the Recombinant VSV (rVSV)-Marburg Virus Vaccine Candidate (PHV01) in Healthy Adult Subjects source ↗
  2. Trial start Phase 1: Study to Evaluate Safety and Immunogenicity of a Prime-Boost Regimen of rVSV-Nipah Virus Vaccine Candidate PHV02 in Healthy Adult Subjects source ↗
  3. Trial start 1: A Phase 1 Study to Evaluate Safety & Immunogenicity of RVSV-Nipah Virus Vaccine Candidate PHV02 in Healthy Adult Subjects source ↗

Clinical trials (lead sponsor) 3

RecordTitlePhaseStatusStartPrimary completion
NCT06265012Study to Evaluate the Recombinant VSV (rVSV)-Marburg Virus Vaccine Candidate (PHV01) in Healthy Adult SubjectsPhase 1CompletedFeb 5, 2024Sep 23, 2024 (actual)
NCT06221813Study to Evaluate Safety and Immunogenicity of a Prime-Boost Regimen of rVSV-Nipah Virus Vaccine Candidate PHV02 in Healthy Adult SubjectsPhase 1CompletedJan 26, 2024Sep 30, 2024 (actual)
NCT05178901A Phase 1 Study to Evaluate Safety & Immunogenicity of RVSV-Nipah Virus Vaccine Candidate PHV02 in Healthy Adult Subjects1CompletedJan 10, 2022May 30, 2023 (actual)
Feedback